Related Experiment Video
Updated: Jul 14, 2026

Application of Retinoic Acid to Obtain Osteocytes Cultures from Primary Mouse Osteoblasts
Published on: May 13, 2014
CCAAT/Enhancer binding protein beta abrogates retinoic acid-induced osteoblast differentiation via repression of
Nadine Wiper-Bergeron1, Catherine St-Louis, Jonathan M Lee
1Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, Ontario, Canada. Nadine.WiperBergeron@uottawa.ca
Abstract:
Runx2/CBFA1/AML3 is a master regulator of the osteoblast lineage and has been shown to directly control the transcription of numerous osteoblast-specific genes including alkaline phosphatase, osteopontin, and type I collagen. In its absence, ossification does not occur during development resulting in animals with cartilaginous skeletons and no osteoblasts. In humans, loss of one copy of Runx2 causes cleidocranial dysplasia characterized by malformations of the facial and cranial bones and the clavicle. Despite its important role in osteoblast biology, relatively little is known about the transcriptional regulation of the Runx2 gene. In the present study, we show that CCAAT/enhancer binding protein beta (C/EBPbeta) is a negative regulator of Runx2 expression and acts by directly binding a C/EBP element located at -591/-576 within the osteoblast-specific Runx2 P1 promoter. Ectopic expression of C/EBPbeta in C3H10T1/2 cells causes a reduction in Runx2 expression concomitant with a decrease in osteogenic potential during all-trans retinoic acid (ATRA)-induced differentiation. In nondifferentiating cells, C/EBPbeta can be found occupying the C/EBP negative response element within the Runx2 P1 promoter. ATRA, the effects of which are mediated by retinoic acid receptor alpha and gamma in C3H10T1/2 cells, stimulates the dissociation of C/EBPbeta from this element and promotes Runx2 expression. Thus, ATRA initiates osteoblastic differentiation of C3H10T1/2 cells, at least in part, by triggering the dissociation of C/EBPbeta from the Runx2 promoter.
Insights
CCAAT/enhancer binding protein beta (C/EBPbeta) negatively regulates Runx2 expression by binding to its promoter. All-trans retinoic acid (ATRA) dissociates C/EBPbeta, promoting osteoblast differentiation.
Area of Science:
- Molecular Biology
- Developmental Biology
- Genetics
Background:
- Runx2 is a master regulator of osteoblast differentiation, essential for bone formation.
- Loss of Runx2 function leads to developmental defects like cleidocranial dysplasia in humans.
- Transcriptional regulation of the Runx2 gene is not fully understood.
Purpose of the Study:
- To investigate the role of CCAAT/enhancer binding protein beta (C/EBPbeta) in regulating Runx2 expression.
- To elucidate the mechanism by which all-trans retinoic acid (ATRA) influences Runx2 expression during osteoblast differentiation.
Main Methods:
- Investigated C/EBPbeta binding to the Runx2 P1 promoter using electrophoretic mobility shift assays.
- Utilized cell culture (C3H10T1/2 cells) to study the effects of C/EBPbeta and ATRA on Runx2 expression and osteogenic potential.
- Examined the role of retinoic acid receptors (RARα and RARγ) in mediating ATRA's effects.
Main Results:
- C/EBPbeta acts as a negative regulator of Runx2 by directly binding to a C/EBP element in the Runx2 P1 promoter.
- Ectopic expression of C/EBPbeta reduced Runx2 expression and osteogenic potential in ATRA-treated cells.
- ATRA treatment stimulated the dissociation of C/EBPbeta from the Runx2 promoter, thereby increasing Runx2 expression.
Conclusions:
- C/EBPbeta is a novel negative regulator of the key osteoblast transcription factor Runx2.
- ATRA-induced osteoblastic differentiation involves the dissociation of C/EBPbeta from the Runx2 promoter, highlighting a new regulatory mechanism.
Related Concept Videos
TGF - β Signaling Pathway
Master Transcription Regulators
Osteoclasts in Bone Remodeling
RNA Polymerase II Accessory Proteins
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Co-activators and Co-repressors

